Back
Nektar Therapeutics Stock Price Chart
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
25
NKTR
Nektar Therapeutics
Last Price:
$0.87
Seasonality Move:
6.78%
7 Day Trial
ALL ACCESS PASS
$
7
The AI Energy Miracle
Details Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.98 | Sell |
| 20-day SMA: | 1.03 | Sell |
| 50-day SMA: | 1.18 | Sell |
| 200-day SMA: | 1.26 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.03 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 1.18 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 33.36 | Sell |
| Chaikin Money Flow: | -107234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.97 - 1.09) | Sell |
| Bollinger Bands (100): | (1.08 - 1.34) | Sell |
Nektar Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.93 while NKTR 8-day simple moving average is 0.98, which is a Sell signal.
-
The stock price of NKTR is 0.93 while Nektar Therapeutics 20-day SMA is 1.03, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 1.18 while NKTR share price is 0.93, making it a Sell technically.
-
NKTR stock price is 0.93 and Nektar Therapeutics 200-day simple moving average is 1.26, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
25
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.93. The Score for NKTR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
171.2M
Price in USD:
0.93
Share Volume:
1.8M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.47
Sell
25
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.93 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.93 while NKTR 8-day exponential moving average is 0.97, which is a Sell signal.
-
The stock price of NKTR is 0.93 while Nektar Therapeutics 20-day EMA is 1.03, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 1.13 while NKTR share price is 0.93, making it a Sell technically.
-
NKTR stock price is 0.93 and Nektar Therapeutics 200-day simple moving average is 1.18, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 33.36, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.97 - 1.09), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (1.08 - 1.34), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.